You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

daratumumab

Showing 26 - 50 of 153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

Active, not recruiting
  • Amyloidosis; Systemic
  • Daratumumab
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 9, 2022

Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Teclistamab (Tec)
  • +4 more
  • Berlin, Germany
  • +8 more
Jan 19, 2023

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • (no location specified)
Nov 29, 2022

Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)

Withdrawn
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jan 26, 2023

Multiple Myeloma Trial in Adelaide, Melbourne, Oslo (XmAb24306, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Adelaide, South Australia, Australia
  • +2 more
Aug 1, 2022

Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • +2 more
  • Rochester, New York
    University of Rochester Medical Center
Jul 8, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Multiple Myeloma Trial in Baltimore (Ciforadenant, daratumumab)

Completed
  • Multiple Myeloma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 9, 2022

Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

Active, not recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 25, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

Not yet recruiting
  • Nephrotic Syndrome
  • Rituximab Biosimilar ABP 798
  • Daratumumab
  • Genova, Italy
    IRCCS G. Gaslini
Jan 19, 2023

Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Active, not recruiting
  • Plasma Cell Myeloma
  • Daratumumab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

Not yet recruiting
  • Antibody-mediated Rejection
  • Kidney Tranplant
  • Daratumumab
  • Hangzhou, Zhejiang, China
    79# Qingchun Road
Jun 21, 2023

Multiple Myeloma Trial in Indianapolis (Lenalidomide Pill, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Lenalidomide Pill
  • +2 more
  • Indianapolis, Indiana
    VA Roudebush Medical Center
Jan 27, 2022

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Daratumumab
  • +2 more
  • Berlin, Germany
  • +9 more
May 27, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Sep 20, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab, Questionnaires)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Mar 4, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Daratumumab
  • +4 more
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022